2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    4 2 0 0

Journal de Mycologie Médicale
Volume 21, n° 4
pages 256-259 (décembre 2011)
Doi : 10.1016/j.mycmed.2011.09.007
Received : 29 September 2010 ;  accepted : 22 September 2011
Prevalence of non-albicans Candida vaginitis in patients on hormonal treatment in Jabalpur, Central India
Prévalence des vaginites à Candida non-albicans chez des patientes sous traitement hormonal à Jabalpur (Inde)

J. Tamsikar a, S.M. Singh a, , J. Naidu b
a Medical Mycology Research Laboratory, Department of Biosciences, R.D. University, Jabalpur 482001, MP, India 
b Department of Zoology & Biotechnology Govt. Autonomous Science College, Jabalpur 482001, MP, India 

Corresponding author. Flat 2C Pavitra Apartments, South Civil Lines, Jabalpur 482001, MP, India.

The aim of this study was to compare the frequency of involvement Candida albicans and non-albicans Candida in patients on hormonal treatment with vulvovaginal candidiasis.

Patients and methods

In the present investigation, 81 women were screened for vulvovaginal infections, of which 43 (53.1%) were positive for Candida infections and four with other fungi. The total patients were categorized into two groups. The patients who had complaint of vaginitis but not taking any kind of other treatment were kept in control group (without hormone) and the patients who had complaint of vaginitis but on hormone treatment for infertility were kept in test group (hormone treated). Out of these 43 patients, 25 (58.2%) were receiving hormones as treatment for infertility or as support for pregnancy. Eighteen patients who had candidal vaginitis but not on the hormone treatment were kept as control group. Samples of vaginal discharge were collected by swab and inoculated onto Sabouraud dextrose agar chloramphenicol. The yeasts isolates were identified by conventional methods.


The highest incidence of infection was found in age group 21–30 years (49%) followed by 31–40 years (37%). The frequency of VVC due to non-albicans Candida species was 64% as compared to 36% caused by C. albicans . In hormone treated group, among non-albicans Candida species highest incidence of vulvovaginitis was due to C. glabrata 06 (24%) followed by C. tropicalis 05 (20%), C. parapsilosis 02 (8%), C. krusei , C. vishwanathii and an unidentified non-albicans Candida species 01each (4%).


The data highlights the emergence of non-albicans Candida infections among patients of vulvovaginal candidiasis (VVC) in Jabalpur hospital (India).

The full text of this article is available in PDF format.

Le but de cette étude était de comparer la fréquence de l’implication de Candida albicans et des Candida non-albicans dans les candidoses vaginales de patientes sous traitement hormonal.

Patientes et méthodes

Dans le présent travail, 81 cas de vulvovaginite ont été étudiés, parmi lesquels 43 étaient dus à Candida et quatre étaient dus à d’autres fungi. Ces 43 patientes ont été réparties en deux groupes : celles (18) qui n’avaient reçu aucun traitement hormonal (groupe contrôle) et celles (25) qui avaient reçu un traitement hormonal pour infertilité (groupe test). Les prélèvements vaginaux ont été ensemencés sur milieu de Sabouraud chloremphénicol. Les levures isolées ont été identifiées par les méthodes conventionnelles.


L’incidence la plus forte de cette infection vulvovaginale concerne les patientes âgées de 21 à 30ans, suivie par les patientes âgées de 31 à 40ans. Les vulvovaginites dues à Candida albicans concernent 36 % des patientes contre 64 % pour celles à Candida non-albicans . Dans le groupe test les Candida non-albicans isolés ont été : C. glabrata (24 %), C. tropicalis (20 %), C. parapsilosis (8 %), C. krusei (4 %), C. viswanathi (4 %) et un Candida non identifié (4 %).


Cette étude a mis en évidence l’émergence des Candida non-albicans dans les candidoses vulvovaginales dans notre hôpital de Jabalpur (Inde).

The full text of this article is available in PDF format.

Keywords : Vulvuvaginal candidiasis, Candida albicans , Non-albicans Candida

Mots clés : Candidose vulvovaginale, Candida albicans , Candida non-albicans

© 2011  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline